Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
Applied DNA Sciences的股票在公司公布的第四季度销售业绩低于预期后下跌,并宣布了包括剥离某些业务部门在内的战略重组计划。
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
Applied DNA Sciences的股价走低,此前该公司公布的第四季度销售业绩低于预期,并宣布了包括剥离某些业务领域的战略重组计划。